Mitral Regurgitation Augments Post-Myocardial Infarction RemodelingFailure of Hypertrophic Compensation
Ronen Beeri, MD*,
Chaim Yosefy, MD*,
J. Luis Guerrero, BS*,
Francesca Nesta, MD*,
Suzan Abedat, MSc ,
Miguel Chaput, MD*,
Federica del Monte, MD, PhD ,
Mark D. Handschumacher, BS*,
Robert Stroud, MS||,
Suzanne Sullivan, BS*,
Thea Pugatsch, PhD ,
Dan Gilon, MD, FACC ,
Gus J. Vlahakes, MD, FACC ,
Francis G. Spinale, MD, FACC||,
Roger J. Hajjar, MD, FACC and
Robert A. Levine, MD, FACC*,*
* Cardiac Ultrasound Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
Cardiac Surgery Department, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
Heart Institute and Cardiovascular Research Laboratory, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
|| Cardiothoracic Surgery Department, Medical University of South Carolina, Charleston, South Carolina.
Manuscript received May 3, 2007;
revised manuscript received July 9, 2007,
accepted July 16, 2007.
* Reprint requests and correspondence: Dr. Robert A. Levine, Cardiac Ultrasound Laboratory YAW5, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114. (Email: rlevine{at}partners.org).
Objectives: We examined whether mitral regurgitation (MR) augments post-myocardial infarction (MI) remodeling.
Background: MR doubles mortality after MI, but its additive contribution to left ventricular (LV) remodeling is debated and has not been addressed in a controlled fashion.
Methods: Apical MIs were created in 12 sheep, and 6 had an LV-to-left atrial shunt implanted, consistently producing regurgitant fractions of 30%. The groups were compared at baseline, 1, and 3 months.
Results: Left ventricular end-systolic volume progressively increased by 190% with MR versus 90% without MR (p < 0.02). Pre-load–recruitable stroke work declined by 82 ± 13% versus 25 ± 16% (p < 0.01) with MR, with decreased remote-zone sarcoplasmic reticulum Ca2+-ATPase levels (0.56 ± 0.03 vs. 0.76 ± 0.02, p < 0.001), and decreased isolated myocyte contractility. In remote zones, pro-hypertrophic Akt and gp130 were upregulated in both groups at 1 month, but significantly lower and below baseline in the MR group at 3 months. Pro-apoptotic caspase 3 remained high in both groups. Matrix metalloproteinase (MMP)-13 and membrane-type MMP-1 were increased in remote zones of MR versus infarct-only animals at 1 month, then fell below baseline. The MMP tissue inhibitors rose from baseline to 3 months in all animals, rising higher in the MI + MR–group border zone.
Conclusions: In this controlled model, moderate MR worsens post-MI remodeling, with reduced contractility. Pro-hypertrophic pathways are initially upregulated but subsequently fall below infarct-only levels and baseline; with sustained caspase 3 elevation, transformation to a failure phenotype occurs. Extracellular matrix turnover increases in MR animals. Therefore, MR can precipitate an earlier onset of dilated heart failure.
|
Abbreviations and Acronyms
| | EF = ejection fraction | | LA = left atrium/atrial | | LV = left ventricle/ventricular | | MI = myocardial infarction | | MMP = matrix metalloproteinase | | MR = mitral regurgitation | | MT-MMP = membrane-type matrix metalloproteinase | | SERCA2a = sarcoplasmic reticulum Ca2+-ATPase | | TIMP = tissue inhibitor of matrix metalloproteinase | | 2D = 2-dimensional | | 3D = 3-dimensional |
|
Related Article
-
The Conundrum of Functional Mitral Regurgitation in Chronic Heart Failure
- Maurice Enriquez-Sarano, Didier F. Loulmet, and Daniel Burkhoff
J. Am. Coll. Cardiol. 2008 51: 487-489.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. Soleimani, M. Khazalpour, G. Cheng, Z. Zhang, G. Acevedo-Bolton, D. A. Saloner, R. Mishra, A. W. Wallace, J. M. Guccione, L. Ge, et al.
Moderate Mitral Regurgitation Accelerates Left Ventricular Remodeling After Posterolateral Myocardial Infarction
Ann. Thorac. Surg.,
November 1, 2011;
92(5):
1614 - 1620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rossi, F. L. Dini, P. Faggiano, E. Agricola, M. Cicoira, S. Frattini, A. Simioniuc, M. Gullace, S. Ghio, M. Enriquez-Sarano, et al.
Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy
Heart,
October 15, 2011;
97(20):
1675 - 1680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pecini, J. J. Thune, C. Torp-Pedersen, C. Hassager, and L. Kober
The relationship between mitral regurgitation and ejection fraction as predictors for the prognosis of patients with heart failure
Eur J Heart Fail,
October 1, 2011;
13(10):
1121 - 1125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Yosefy, R. Beeri, J. L. Guerrero, M. Vaturi, M. Scherrer-Crosbie, M. D. Handschumacher, and R. A. Levine
Mitral Regurgitation After Anteroapical Myocardial Infarction: New Mechanistic Insights
Circulation,
April 12, 2011;
123(14):
1529 - 1536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Messas, A. Bel, C. Szymanski, I. Cohen, B. Touchot, M. D. Handschumacher, M. Desnos, A. Carpentier, P. Menasche, A. A. Hagege, et al.
Relief of Mitral Leaflet Tethering Following Chronic Myocardial Infarction by Chordal Cutting Diminishes Left Ventricular Remodeling
Circ Cardiovasc Imaging,
November 1, 2010;
3(6):
679 - 686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Beeri, M. Chaput, J. L. Guerrero, Y. Kawase, C. Yosefy, S. Abedat, I. Karakikes, C. Morel, A. Tisosky, S. Sullivan, et al.
Gene Delivery of Sarcoplasmic Reticulum Calcium ATPase Inhibits Ventricular Remodeling in Ischemic Mitral Regurgitation
Circ Heart Fail,
September 1, 2010;
3(5):
627 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Levine and S. Nattel
Looking Into the Left Atrial Crystal Ball: A Ray of Hope for Patients With Organic Mitral Regurgitation
J. Am. Coll. Cardiol.,
August 10, 2010;
56(7):
579 - 581.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bursi, A. Barbieri, F. Grigioni, L. Reggianini, V. Zanasi, C. Leuzzi, C. Ricci, G. Piovaccari, A. Branzi, and M. G. Modena
Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study
Eur J Heart Fail,
April 1, 2010;
12(4):
382 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Di Salvo, M. A. Acker, G. W. Dec, and J. G. Byrne
Mitral Valve Surgery in Advanced Heart Failure
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
271 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pu, Z. Gao, X. Zhang, D. Liao, D. K. Pu, T. Brennan, and W. R. Davidson Jr.
Impact of mitral regurgitation on left ventricular anatomic and molecular remodeling and systolic function: implication for outcome
Am J Physiol Heart Circ Physiol,
June 1, 2009;
296(6):
H1727 - H1732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Enriquez-Sarano, D. F. Loulmet, and D. Burkhoff
The Conundrum of Functional Mitral Regurgitation in Chronic Heart Failure
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
487 - 489.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Levine and R. Durst
MITRAL VALVE PROLAPSE: A DEEPER LOOK.
J. Am. Coll. Cardiol. Img.,
January 1, 2008;
1(3):
304 - 306.
[Full Text]
[PDF]
|
 |
|
|